PMV Pharmaceuticals, Inc. announced the appointment of Charles M. Baum, M.D., Ph.D., to its Board of Directors. Dr. Baum has served as the President and Chief Executive Officer and as a Board Member of Mirati Therapeutics Inc. since 2012. Under his leadership, Mirati has transformed into a precision oncology company focused on advancing its drug discovery and research and delivering novel therapeutics that target the genetic and immunologic drivers of cancer.